Status:
RECRUITING
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Lead Sponsor:
Gelb, Arthur F., M.D.
Conditions:
Asthma
Eligibility:
All Genders
10-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the site and mechanisms responsible for expiratory airflow limitation in chronic, treated, non-smoking, stable asthmatics with moderate to severe persistent ex...
Detailed Description
In addition we will also obtain above studies in asthmatics during naturally occuring exacerbation of asthma and following treatment. If available, results of lung function studies including measureme...
Eligibility Criteria
Inclusion
- Current non-smoking (\<10 pack yr smoking history)
- Stable, treated asthmatics
- Age 10-80 yr
- post 180ug albuterol by MDI: FEV 1/FVC \< 70% and FEV 1 \<80% predicted
Exclusion
- Pregnancy
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01225913
Start Date
October 1 2007
End Date
June 1 2027
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arthur F Gelb Medical Corporation
Lakewood, California, United States, 90712